XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components (Tables)
 9 Months Ended
Sep. 30, 2022
Balance Sheet Related Disclosures [Abstract]  
Schedule of Intangible Assets Intangible assets consisted of the following (in thousands of dollars):
 September 30, 2022December 31, 2021Weighted Average Remaining Amortization Period (Years)
 Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Percepta product technology$16,000 $(8,000)$8,000 $16,000 $(7,200)$8,800 7
Prosigna product technology4,120 (778)3,342 4,120 (572)3,548 11
Prosigna customer relationships2,430 (1,377)1,053 2,430 (1,013)1,417 1
nCounter Dx license46,880 (8,855)38,025 46,880 (6,511)40,369 11
LymphMark product technology990 (401)589 990 (295)695 4
Decipher product technology90,000 (13,984)76,016 90,000 (7,234)82,766 8
Decipher trade names4,000 (1,243)2,757 4,000 (643)3,357 3
HalioDx developed technology36,367 (4,500)31,867 45,640 (1,877)43,763 9
HalioDx customer relationships4,213 (861)3,352 4,870 (352)4,518 6
HalioDx customer backlog5,976 (1,735)4,241 6,908 (710)6,198 2
Total finite-lived intangibles210,976 (41,734)169,242 221,838 (26,407)195,431 8.9
In-process research and development7,300 — 7,300 7,300 — 7,300 
Total intangible assets$218,276 $(41,734)$176,542 $229,138 $(26,407)$202,731 
Schedule of Future Aggregate Amortization Expense The estimated future aggregate amortization expense as of September 30, 2022 is as follows (in thousands of dollars):
Year Ending December 31,Amounts
2022 remainder of year$5,184 
202320,735 
202420,695 
202519,635 
202617,899 
Thereafter85,094 
Total$169,242 
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following (in thousands of dollars):
 
 September 30, 2022December 31, 2021
Accrued compensation expenses$25,732 $30,792 
Accrued other6,405 8,683 
Total accrued liabilities$32,137 $39,475